Keller, Michael D. http://orcid.org/0000-0001-8323-3085
Schattgen, Stefan A. http://orcid.org/0000-0002-6860-5079
Chandrakasan, Shanmuganathan http://orcid.org/0000-0001-8007-9932
Allen, E. Kaitlynn http://orcid.org/0000-0002-3067-751X
Jensen-Wachspress, Mariah A.
Lazarski, Christopher A. http://orcid.org/0000-0001-8917-7280
Qayed, Muna
Lang, Haili
Hanley, Patrick J.
Tanna, Jay
Pai, Sung-Yun http://orcid.org/0000-0002-0158-8147
Parikh, Suhag http://orcid.org/0000-0002-6066-9852
Berger, Seth I. http://orcid.org/0000-0001-7517-4302
Gottschalk, Stephen http://orcid.org/0000-0003-3991-7468
Pulsipher, Michael A.
Thomas, Paul G. http://orcid.org/0000-0001-7955-0256
Bollard, Catherine M. http://orcid.org/0000-0001-5140-9090
Funding for this research was provided by:
California Institute for Regenerative Medicine (CLIN2-10392)
Article History
Received: 19 September 2022
Accepted: 20 December 2023
First Online: 29 March 2024
Competing interests
: CMB is on the scientific advisory boards for Catamaran Bio and Mana Therapeutics with stock and/or ownership, is on the Board of Directors for Caballeta Bio with stock options and has stock in Neximmune and Repertoire Immune Medicines and serves on the DSMB of SOBI. MAP is on Advisory boards—Novartis, Gentibio, Bluebird, Vertex, Medexus, Equillium; and Study Support—Adaptive, Miltenyi. PJH is a Co-founder and Board of Directors: Mana Therapeutics; and Scientific Advisory Board: Cellevolve, Cellenkos, Capsida, MicrofluidX, Discovery Life Sciences. MDK is an author for Elsevier (Uptodate), and has received research funding from Chiesi Pharmaceuticals. SC is on SAB/ Honoraria from SOBI, honoraria from Pharming P.G.T. has consulted and/or received honoraria and travel support from Illumina, Johnson and Johnson, and 10X Genomics. P.G.T. serves on the Scientific Advisory Board of Immunoscape and Cytoagents. The remaining authors declare no competing interests.